Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AUDIOEYE INCAEYE · Entity 6844 | Director | October 01, 2026 | October 03, 2026 |
| IRADIMED CORPIRMD · Entity 4896 | Director | December 11, 2025 | December 15, 2025 |
| NATUS MEDICAL INCBABY · Entity 125256 | Director · President and CEO | April 30, 2018 | May 02, 2018 |
| OSI SYSTEMS INCOSIS · Entity 4160 | Director | August 20, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AUDIOEYE INC
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 218,684 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,000 · Balance 218,684 F1: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date.
IRADIMED CORP
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,932 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 1,026 · Balance 1,932 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
NATUS MEDICAL INC
Report date April 30, 2018 · Filed May 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 639,257 |
Ending reported balance
After 2018-04-30 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2018-04-30 · Exercise / conversion · Acquired 47,500 · Balance 686,757 Row 2 · 2018-04-30 · Sale · Disposed 47,500 · Balance 639,257 F1: This transaction was executed in multiple trades at prices ranging from $32.90 to $34.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2018-04-30 · Exercise / conversion · Acquired 76,827 · Balance 716,084 Row 4 · 2018-04-30 · Sale · Disposed 76,827 · Balance 639,257 F2: This transaction was executed in multiple trades at prices ranging from $33.05 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2018-04-30 · Exercise / conversion · Acquired 35,673 · Balance 674,930 Row 6 · 2018-04-30 · Sale · Disposed 35,673 · Balance 639,257 F3: This transaction was executed in multiple trades at prices ranging from $32.65 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 112,500 |
Reported balance
After 2018-04-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-04-30 · Exercise / conversion · Disposed 47,500 · Balance 112,500 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 35,673 |
Reported balance
After 2018-05-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-05-01 · Exercise / conversion · Disposed 76,827 · Balance 35,673 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-07 | Direct | 0 |
Reported balance
After 2018-05-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-05-02 · Exercise / conversion · Disposed 35,673 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $32.90 to $34.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $33.05 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $32.65 to $33.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
OSI SYSTEMS INC
Report date August 20, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,295 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Tax withholding · Disposed 90 · Balance 5,295 F1: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Caesars Entertainment, Inc.
Report date July 20, 2020 · Filed July 23, 2020
Section 16 reporting ended · disclosed 2020-07-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,082 |
Ending reported balance
After 2020-07-20 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2020-07-20 · Exercise / conversion · Acquired 9,256 · Balance 91,256 F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 2 · 2020-07-20 · Exercise / conversion · Acquired 17,980 · Balance 109,236 F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 3 · 2020-07-20 · Exercise / conversion · Acquired 6,984 · Balance 116,220 F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 4 · 2020-07-20 · Exercise / conversion · Acquired 4,612 · Balance 120,832 F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 5 · 2020-07-20 · Exercise / conversion · Acquired 4,305 · Balance 125,137 F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. Row 6 · 2020-07-20 · Exercise / conversion · Acquired 2,945 · Balance 128,082 F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-07-20 · Exercise / conversion · Disposed 9,256 · Balance 0 F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-07-20 · Exercise / conversion · Disposed 17,980 · Balance 0 F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-07-20 · Exercise / conversion · Disposed 6,984 · Balance 0 F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-07-20 · Exercise / conversion · Disposed 4,612 · Balance 0 F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-07-20 · Exercise / conversion · Disposed 4,305 · Balance 0 F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2020-07-20 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-07-20 · Exercise / conversion · Disposed 2,945 · Balance 0 F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with Eldorado Resorts, Inc. (n/k/a Caesars Entertainment, Inc., the "Company"), all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F2: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F3: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F4: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F5: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
F6: Each Restricted Stock Unit represented the economic equivalent of one share of the Company's common stock. In connection with the reporting person's separation from service with the Company, all of the shares underlying the Restricted Stock Unit were settled for shares of the Company's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:10 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-26-000023 · form4-10022026_081031.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,684 F1 · shares: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 20:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 90 | $220.92 | $19,882.80 |
DisclosureSEC source: 0000898243-26-000021 · form4-08212026_040808.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,295 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 144 | $228.56 | $32,912.64 |
DisclosureSEC source: 0000898243-26-000019 · form4-08172026_040806.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,385 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. F2 · balance_after: The amount of securities beneficially owned following the reported transaction has been adjusted to reflect the reduction of 15 shares that were inadvertently omitted from prior ownership reports. This adjustment corrects the reporting of the Reporting Person's beneficial ownership and does not result from a current transaction. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 20:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 170 | $217.30 | $36,941.00 |
DisclosureSEC source: 0000898243-26-000017 · form4-07292026_040701.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,544 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 20:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | GrantCommon Stock | 924 | $216.65 | $200,184.60 |
DisclosureSEC source: 0000898243-26-000015 · form4-07212026_040705.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,714 Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 22:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 231 | $221.76 | $51,226.56 |
DisclosureSEC source: 0000898243-26-000013 · form4-07072026_060706.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,790 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-26-000011 · form4-07022026_080721.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,684 F1 · shares: The securities relate to a quarterly grant of shares of common stock under the AudioEye, Inc. 2020 Equity Incentive Plan, which shares were fully vested on the grant date. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:14 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-26-000009 · form4-06242026_080610.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,684 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the AudioEye, Inc. 2020 Equity Incentive Plan, which RSUs will vest on the earlier of (a) one year following the date of the grant or (b) immediately prior to the next annual meeting of stockholders following the date of grant, provided the director's service has not terminated prior to such date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:30 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-26-000007 · form4-04032026_040433.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,184 F1 · shares: The securities relate to a quarterly grant of restricted stock units ("RSUs") under the AudioEye, Inc. 2020 Equity Incentive Plan, which RSUs vested on the grant date and will be settled on the earlier of (i) the third anniversary of the grant date, (ii) immediately prior to the closing of a change in control, but in no case later than 90 days following the change in control, and (iii) the calendar year following the year of death, with payment being made in no case later than the end of the year following the year of death. Read SEC document |
| March 12, 2026 Filed Mar 12, 2026 20:20 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 11,000 | $5.64 | $62,031.20 |
DisclosureSEC source: 0000898243-26-000005 · form4-03122026_080352.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,517 F3 · price: Reflects the weighted average price of 11,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on March 12, 2026 with purchase prices ranging from $5.58 to $5.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 20:20 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 13,000 | $5.77 | $74,999.60 |
DisclosureSEC source: 0000898243-26-000005 · form4-03122026_080352.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,517 F2 · price: Reflects the weighted average price of 13,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on March 11, 2026 with purchase prices ranging from $5.70 to $5.88 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:20 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 14,000 | $5.91 | $82,713.40 |
DisclosureSEC source: 0000898243-26-000005 · form4-03122026_080352.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,517 F1 · price: Reflects the weighted average price of 14,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on March 10, 2026 with purchase prices ranging from $5.75 to $6.03 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:44 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-26-000002 · form4-01052026_090136.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,517 F1 · shares: The securities relate to a quarterly grant of restricted stock units ("RSUs") under the AudioEye, Inc. 2020 Equity Incentive Plan, which RSUs vested on the grant date and will be settled on the earlier of (i) the third anniversary of the grant date, (ii) immediately prior to the closing of a change in control, but in no case later than 90 days following the change in control, and (iii) the calendar year following the year of death, with payment being made in no case later than the end of the year following the year of death. Read SEC document |
| December 13, 2025 Filed Dec 16, 2025 21:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 15 | $259.44 | $3,891.60 |
DisclosureSEC source: 0000898243-25-000031 · form4-12162025_041203.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,021 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 905 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-25-000026 · form4-12122025_051213.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 906 Underlying: Common Stock · 905 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 905 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898243-25-000026 · form4-12122025_051213.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 22:30 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-25-000028 · form4-12152025_051203.xml · derivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,932 Underlying: Common Stock · 1,026 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,000 | $96.61 | $289,837.50 |
DisclosureSEC source: 0000898243-25-000024 · form4-12102025_051201.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,742 F1 · price: This transaction was executed in multiple trades at prices ranging from $96.50 to $97.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 07, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-25-000022 · form4-12092025_051208.xml · derivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2025 Filed Dec 9, 2025 22:00 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898243-25-000022 · form4-12092025_051208.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 21:13 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 2,000 | $11.05 | $22,100.00 |
DisclosureSEC source: 0000898243-25-000020 · form4-11242025_091154.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,850 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,000 | $88.00 | $88,000.00 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 6 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,545 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,000 | $88.50 | $88,500.00 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,545 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 772 | $88.20 | $68,090.40 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,545 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 100 | $88.26 | $8,826.00 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,317 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 100 | $88.28 | $8,828.00 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,417 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 21:05 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 28 | $88.29 | $2,472.12 |
DisclosureSEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,517 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:13 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 2,000 | $11.60 | $23,200.00 |
DisclosureSEC source: 0000898243-25-000020 · form4-11242025_091154.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,850 Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 21:44 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 2,000 | $11.40 | $22,795.00 |
DisclosureSEC source: 0000898243-25-000013 · form4-11192025_091134.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,850 Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:44 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 2,000 | $11.57 | $23,149.60 |
DisclosureSEC source: 0000898243-25-000013 · form4-11192025_091134.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,850 Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 00:34 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 6,000 | $11.90 | $71,419.80 |
DisclosureSEC source: 0000898243-25-000011 · form4-11142025_121101.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,850 F1 · price: Reflects the weighted average price of 6,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on November 13, 2025 with purchase prices ranging from $11.80 to $12.01 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 11:00 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 8,000 | $12.58 | $100,600.00 |
DisclosureSEC source: 0000898243-25-000009 · form4-11122025_061103.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,850 F1 · price: Reflects the weighted average price of 8,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on November 11, 2025 with purchase prices ranging from $12.50 to $12.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 07, 2025 Filed Nov 8, 2025 02:50 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | SaleCommon Stock | 1,500 | $283.15 | $424,725.00 |
DisclosureSEC source: 0000898243-25-000008 · form4-11072025_091101.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,036 F1 · price: This transaction was executed in multiple trades at prices ranging from $283.00 to $284.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:20 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000898243-25-000004 · form4-10032025_081001.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,850 F1 · shares: The securities relate to a quarterly grant of restricted stock units ("RSUs") under the AudioEye, Inc. 2020 Equity Incentive Plan, which RSUs vested on the grant date and will be settled on the earlier of (i) the third anniversary of the grant date, (ii) immediately prior to the closing of a change in control, but in no case later than 90 days following the change in control, and (iii) the calendar year following the year of death, with payment being made in no case later than the end of the year following the year of death. Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 21:11 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | GrantCommon Stock | 895 | $223.39 | $199,934.05 |
DisclosureSEC source: 0001415889-25-022775 · form4-08222025_090803.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,536 Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 23:31 UTC | AUDIOEYE INC AEYE · Entity 6844 | PurchaseCommon Stock | 8,000 | $10.95 | $87,560.00 |
DisclosureSEC source: 0001415889-25-022368 · form4-08192025_110813.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,183 F1 · price: Reflects the weighted average price of 8,000 shares of common stock of AudioEye, Inc. purchased by the reporting person in multiple transactions on August 18, 2025 with purchase prices ranging from $10.92 to $10.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 23:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 144 | $236.05 | $33,991.20 |
DisclosureSEC source: 0001415889-25-022117 · form4-08152025_070801.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,641 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 28, 2025 Filed Jul 31, 2025 10:00 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 170 | $226.08 | $38,433.60 |
DisclosureSEC source: 0001415889-25-020668 · form4-07312025_060701.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,785 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 01:50 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 196 | $230.81 | $45,238.76 |
DisclosureSEC source: 0001415889-25-019559 · form4-07082025_090702.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,955 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 06, 2025 Filed Jul 9, 2025 01:50 UTC | OSI SYSTEMS INC OSIS · Entity 4160 | Tax withholdingCommon Stock | 230 | $232.51 | $53,477.30 |
DisclosureSEC source: 0001415889-25-019559 · form4-07082025_090702.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,151 F1 · shares: Pursuant with a net settlement, shares of stock were tendered to pay for the tax withholding. No shares of stock were sold. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 21:04 UTC | AUDIOEYE INC AEYE · Entity 6844 | GrantCommon Stock | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019349 · form4-07032025_090749.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,183 F1 · shares: The securities relate to a quarterly grant of restricted stock units ("RSUs") under the AudioEye, Inc. 2020 Equity Incentive Plan, which RSUs vested on the grant date and will be settled on the earlier of (i) the third anniversary of the grant date, (ii) immediately prior to the closing of a change in control, but in no case later than 90 days following the change in control, and (iii) the calendar year following the year of death, with payment being made in no case later than the end of the year following the year of death. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherPut Option (obligation to buy) · Derivative | 10 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001415889-25-018113 · form4-06242025_090601.xml · derivative · entry 5 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-20 Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherPut Option (obligation to buy) · Derivative | 76 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001415889-25-018113 · form4-06242025_090601.xml · derivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,600 shares Expires 2025-06-20 Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherPut Option (obligation to buy) · Derivative | 10 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001415889-25-018113 · form4-06242025_090601.xml · derivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-20 Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherCommon Stock | 7,600 | $15.00 | $114,000.00 |
DisclosureSEC source: 0001415889-25-018113 · form4-06242025_090601.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,516 Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 21:18 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001415889-25-018113 · form4-06242025_090601.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,916 Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:55 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherPut Option (obligation to buy) · Derivative | 54 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017639 · form4-06182025_120630.xml · derivative · entry 4 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,600 Underlying: Common Stock · 5,400 shares Expires 2025-06-20 Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:55 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherCommon Stock | 5,400 | $15.00 | $81,000.00 |
DisclosureSEC source: 0001415889-25-017639 · form4-06182025_120630.xml · nonDerivative · entry 2 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,916 Read SEC document |
| June 12, 2025 Filed Jun 18, 2025 00:55 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherPut Option (obligation to buy) · Derivative | 10 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017639 · form4-06182025_120630.xml · derivative · entry 3 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 1,000 shares Expires 2025-06-20 Read SEC document |
| June 12, 2025 Filed Jun 18, 2025 00:55 UTC | AUDIOEYE INC AEYE · Entity 6844 | OtherCommon Stock | 1,000 | $15.00 | $15,000.00 |
DisclosureSEC source: 0001415889-25-017639 · form4-06182025_120630.xml · nonDerivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,516 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.